Individual results may vary.
Now that you've learned about COSENTYX® for ankylosing spondylitis, here's a reminder of the results you could expect.
6 OUT OF 10 PEOPLE NOTICED AT LEAST A
IMPROVEMENT IN SYMPTOMS OF AS VERSUS 3 OUT OF 10 TAKING A PLACEBO
In clinical trials, at 16 weeks approximately 6 out of 10 people noticed at least a 20% improvement in symptoms, and approximately 4 out of 10 people saw at least a 40% improvement in symptoms of AS versus 1 out of 10 taking a placebo.
At 16 weeks, some people taking COSENTYX in clinical trials experienced:
In a clinical trial with COSENTYX, patients completed a questionnaire that asked how difficult it was to perform daily activities, which included:
BENDING FROM THE WAIST TO PICK UP AN ITEM OFF THE FLOOR WITHOUT AN AID
DOING PHYSICALLY DEMANDING ACTIVITIES (SUCH AS GARDENING OR SPORTS)
DOING A FULL DAY OF ACTIVITIES AT WORK OR HOME
CLIMBING 12–15 STEPS WITHOUT USING A HANDRAIL OR WALKING AID
COSENTYX has been studied in clinical trials for AS since 2011.
COSENTYX is the first medicine of its kind for ankylosing spondylitis. Itís the only FDA-approved medication for ankylosing spondylitis that specifically targets IL-17A.
COSENTYX is a once-a-month injection. Your doctor may prescribe 5 weekly doses to get you started if he or she thinks it's necessary. The recommended dose is 150 mg used under the skin.
You may be eligible for our $0 co-pay* program if you're commercially insured.
Do not use COSENTYX if you have had a severe allergic reaction to secukinumab or any of the other ingredients in COSENTYX. See the Medication Guide for a complete list of ingredients.
COSENTYX is a medicine that affects your immune system. COSENTYX may increase your risk of having serious side effects such as:
COSENTYX may lower the ability of your immune system to fight infections and may increase your risk of infections.
New cases of inflammatory bowel disease or "flare-ups" can happen with COSENTYX, and can sometimes be serious. If you have inflammatory bowel disease (ulcerative colitis or Crohn’s disease), tell your doctor if you have worsening disease symptoms during treatment with COSENTYX or develop new symptoms of stomach pain or diarrhea.
Serious allergic reactions can occur. Get emergency medical help right away if you get any of the following symptoms: feeling faint; swelling of your face, eyelids, lips, mouth, tongue, or throat; trouble breathing or throat tightness; chest tightness; or skin rash. If you have a severe allergic reaction, do not give another injection of COSENTYX.
Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Know the medicines you take. Keep a list of your medicines to show your doctor and pharmacist when you get a new medicine.
How should I use COSENTYX?
See the detailed Instructions for Use that comes with your COSENTYX for information on how to prepare and inject a dose of COSENTYX, and how to properly throw away (dispose of) used COSENTYX Sensoready® pens and prefilled syringes.
The most common side effects of COSENTYX include: cold symptoms, diarrhea, and upper respiratory infections. These are not all of the possible side effects of COSENTYX. Call your doctor for medical advice about side effects.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
COSENTYX® (secukinumab) is a prescription medicine used to treat adults with moderate to severe plaque psoriasis that involves large areas or many areas of the body, and who may benefit from taking injections or pills (systemic therapy) or phototherapy (treatment using ultraviolet or UV light, alone or with systemic therapy).